Microfluidic silicon probe could improve disease diagnostics

Microfluidic silicon probe could improve disease diagnostics:

IBM scientists in Zurich have created a proof-of-concept device, that could change the way that human tissue samples are analyzed. Presently, samples must be stained with a biomarker solution in order to detect the presence of a disease. The staining process can be quite involved, however, plus it is subject to error – too much of the solution can cause inaccurate results, for instance. Additionally, it can sometimes be difficult to perform enough tests using the small amount of tissue extracted in most biopsies. The IBM technology, though it still involves staining, is said to offer a potential solution to these shortcomings...
Continue Reading Microfluidic silicon probe could improve disease diagnostics

Section: Research Watch

Tags: Disease,
IBM,
Medical Imaging,
Microfluidic



Related Articles:

• Alzheimer's detection using near-infrared light


• Device developed to more efficiently find buried bodies


• Tiny particles measure microRNA to detect cancer


• Wireless chips and probes could monitor orthopedic implants


• Biomarker research could lead to finger-prick cancer test


• Gold nanowires used in promising new heart patches